Kathryn E. Wengel
CIK: 0001745955
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Jun 11, 2026JNJ
JOHNSON & JOHNSON
Sale(S)Direct10K shares at avg. $241.15$2.4M - Jun 11, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct10K shares at avg. $115.67$1.2M - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Award(A)DirectEmployee Stock Options (Right to Buy)
16.9K shares- - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct606 shares- - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct310 shares at avg. $243.45$75K - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct635 shares- - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct325 shares at avg. $243.45$79K - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Award(A)DirectRestricted Share Units
1.2K shares- - Feb 13, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct13.7K shares- - Feb 13, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct217 shares at avg. $244.55$53K - Feb 13, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct6.4K shares at avg. $244.55$1.6M - Feb 13, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct651 shares- - Feb 11, 2026LH
LABCORP HOLDINGS INC.
Exercise(M)Direct897 shares- - Feb 10, 2026LH
LABCORP HOLDINGS INC.
Award(A)DirectRestricted Stock Unit
773 shares- - Feb 9, 2026JNJ
JOHNSON & JOHNSON
Award(A)DirectPerformance Share Units
13.7K shares- - Feb 6, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct38.9K shares at avg. $101.87$4.0M - Feb 6, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct27.3K shares at avg. $239.99$6.5M - Feb 18, 2025JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct200 shares at avg. $156.15$31K - Feb 15, 2025JNJ
JOHNSON & JOHNSON
Award(A)DirectEmployee Stock Options (Right to Buy)
30.8K shares- - Feb 15, 2025JNJ
JOHNSON & JOHNSON
Award(A)DirectRestricted Share Units
1.9K shares- - Feb 15, 2025JNJ
JOHNSON & JOHNSON
Exercise(M)Direct607 shares- - Feb 14, 2025JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct2.4K shares at avg. $156.71$375K - Feb 14, 2025JNJ
JOHNSON & JOHNSON
Exercise(M)Direct1.5K shares- - Feb 14, 2025JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct223 shares at avg. $155.26$35K - Feb 14, 2025JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct480 shares at avg. $156.71$75K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  JNJ JOHNSON & JOHNSON | Sale(S) | 10,000 | $241.15 | $2,411,500 | Direct |
| Jun 11, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 10,000 | $115.67 | $1,156,700 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Award(A) Employee Stock Options (Right to Buy) | 16,945 | - | - | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 606 | - | $0 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 310 | $243.45 | $75,470 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 635 | - | $0 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 325 | $243.45 | $79,121 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Award(A) Restricted Share Units | 1,217 | - | - | Direct |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 13,706 | - | $0 | Direct |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 217 | $244.55 | $53,067 | Direct |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 6,414 | $244.55 | $1,568,544 | Direct |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 651 | - | $0 | Direct |
| Feb 11, 2026 |  LH LABCORP HOLDINGS INC. | Exercise(M) | 897 | - | $0 | Direct |
| Feb 10, 2026 | LH LABCORP HOLDINGS INC. | Award(A) Restricted Stock Unit | 773 | - | - | Direct |
| Feb 9, 2026 | JNJ JOHNSON & JOHNSON | Award(A) Performance Share Units | 13,706 | - | - | Direct |
| Feb 6, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 38,945 | $101.87 | $3,967,327 | Direct |
| Feb 6, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 27,270 | $239.99 | $6,544,527 | Direct |
| Feb 18, 2025 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 200 | $156.15 | $31,230 | Direct |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | Award(A) Employee Stock Options (Right to Buy) | 30,841 | - | - | Direct |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | Award(A) Restricted Share Units | 1,903 | - | - | Direct |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | Exercise(M) | 607 | - | - | Direct |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 2,393 | $156.71 | $375,007 | Direct |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | Exercise(M) | 1,530 | - | - | Direct |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 223 | $155.26 | $34,623 | Direct |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 480 | $156.71 | $75,221 | Direct |
1-25 of 32 transactions
About Wengel Kathryn E
Wengel Kathryn E (SEC CIK 0001745955) files insider reports with the SEC as EVP, Chief TO and Risk Officer of JOHNSON & JOHNSON (JNJ) and Director of LABCORP HOLDINGS INC. (LH).
Signal8 holds 12 ownership filings by Wengel Kathryn E, all Form 4s, filed between Feb 10, 2025 and Jun 12, 2026. Those filings report 32 transactions, from Feb 6, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wengel Kathryn E's filings is in NEW BRUNSWICK, NJ.
Recent filings by Wengel Kathryn E
- Jun 11, 2026: Open-market sale of JNJ shares (Form 4, code S).
- Jun 11, 2026: Option exercise of JNJ shares (Form 4, code M).
- Feb 15, 2026: Grant or award of JNJ derivative securities (Form 4, code A).
- Feb 15, 2026: Option exercise of JNJ shares (Form 4, code M).
- Feb 15, 2026: Tax withholding of JNJ shares (Form 4, code F).
Other insiders filing for JOHNSON & JOHNSON (JNJ)
- Pinto Daniel E, Director
- Woods Eugene A., Director
- HEWSON MARILLYN A, Director
- Schmid Timothy, EVP, WW Chair, MedTech
- Cavanaugh Thomas, EVP WW Chair, Innovative Med.
- Taubert Jennifer L, EVP, WWC. Innovative Medicine